Empirical Drug Dosage Validates Pharmacogenomic Associations in All of Us
Clinical and Translational Science · 2025-11 · 18 (11)
DOI: 10.1111/cts.70406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 15.11.2025. Verfasst von Jan Matthias und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology (D-HEST), ETH Zurich, Zürich, Switzerland. Hauptthemen laut MEDLINE: Cytochrome P-450 Enzyme System, Pharmacogenetics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, Burroughs Wellcome Fund under their Innovations in Regulatory Science Awards program.
Abstract (Originalsprache)
The All of Us research program, a national longitudinal study conducted by the US National Institutes of Health, provides robust medical history, drug dosage and genomic data from a diverse population. All of Us offers an opportunity to discover novel correlations between drug dosage and genetic variation. However, first it is necessary to evaluate the quality and quantity of the data and its ability to replicate known associations. In this paper, we investigate whether known drug‐gene interactions can be recovered from the All of Us dataset, based on data from electronic health records. Focusing on the Cytochrome P450 (CYP450) enzyme family, which metabolizes approximately 90% of clinically available drugs, we evaluate 61 drugs metabolized by the enzymes. We then identify significant differences in drug dosages across CYP450 metabolizer phenotypes. Our results validate some known interactors of CYP2D6, CYP2C19, CYP2C9, and CYP3A5. However, we did not recover all validated PGx interactions, potentially due to noise, lack of doctors adjusting drug dosage or phenoconversion. Nevertheless, our findings highlight the potential of the All of Us dataset, which captures some known pharmacogenomic interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences and Technology (D-HEST), ETH Zurich, Zürich, Switzerland.
- Department of Bioengineering, Stanford University, Stanford, California, USA.
- Open Targets, Hinxton, UK.
- European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.
- Department of Genetics, Stanford University, Stanford, California, USA.
ORCID-Profile: Jan Matthias, Maria J Falaguera, Russ B Altman
Förderung
- NIGMS NIH HHS
- NIH HHS
- Burroughs Wellcome Fund under their Innovations in Regulatory Science Awards program
- Burroughs Wellcome Fund
- National Institutes of Health
Zitieren
APA
Matthias, J., Falaguera, M. J., & Altman, R. B. (2025). Empirical Drug Dosage Validates Pharmacogenomic Associations in All of Us. Clinical and Translational Science, 18(11). https://doi.org/10.1111/cts.70406
Vancouver
Matthias J, Falaguera MJ, Altman RB. Empirical Drug Dosage Validates Pharmacogenomic Associations in All of Us. Clinical and Translational Science. 2025;18(11). doi:10.1111/cts.70406
BibTeX
@article{Matthias2025,
author = {Matthias, Jan and Falaguera, Maria J and Altman, Russ B},
title = {Empirical Drug Dosage Validates Pharmacogenomic Associations in All of Us},
journal = {Clinical and Translational Science},
year = {2025},
volume = {18},
number = {11},
doi = {10.1111/cts.70406}
}
EUVIMED